Andrés González Santana is originally from Tenerife (Canary Islands, Spain), where he obtained his university degree in Organic Chemistry in 2005 (valedictorian) from Universidad de La Laguna. Next, he moved to Madrid to continue his postgraduate studies at the Universidad Complutense, where he obtained his M.Sc. (Organic & Medicinal Chemistry). In 2007 he joined the group of Prof. Suárez (Institute of Natural Products - CSIC) to carry out PhD studies on the homolytic fragmentation of anomeric radicals and the exploitation of this reaction with synthetic purposes, with an emphasis on the biological applications of the synthesized molecules, which he defended in June 2012. In 2013 he was recruited by Prof. Stephen Withers as a postdoctoral fellow at the University of British Columbia (Vancouver, Canada). During the first months of his stay he was able to secure a highly competitive EMBO long-term postdoctoral fellowship. During this period, he worked in parallel projects in the field of glycochemistry, with an emphasis on the discovery of human glucocerebrosidase (GCase) inhibitors to be used as pharmacological chaperones for the treatment of Gaucher disease, in collaboration with the Centre for Drug Research and Development (CDRD) at UBC, as well as with the Child and Family Health Research Institute. In 2016 he moved back to Spain, where he started working at the Institute of Organic Chemistry (IQOG - CSIC, Madrid) under the supervision of Dr Asensio in a dynamic combinatorial approach to study aromatic/carbohydrate interactions and the application in NMR-screening protocols for the discovery and optimization of nucleic acid binders. Andrés has authored more than 20 peer-review articles and has participated in numerous national and international conferences, both as attendant and speaker. Currently, he holds a Juan de la Cierva postdoctoral fellowship, and as of January next year he will be a Marie Sklodowska Curie fellow.